Planning Strategies’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$542 Hold
1
– – ﹤0.01% 914
2026
Q2
$542 Buy
+1
New +$563 ﹤0.01% 846

Other funds holding UTHR

Planning Strategies's UTHR Position: Q3 2026 in Review

Planning Strategies held its United Therapeutics (UTHR) position steady in Q3 2026 at 1 share worth $542. The position accounts for ﹤0.01% of the portfolio, ranked #914.

Planning Strategies first reported a position in UTHR in Q2 2026 and has held it in 2 quarters since. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Planning Strategies held 1 share of United Therapeutics worth $542 as of Q3 2026.
  • Planning Strategies left its United Therapeutics share count unchanged in Q3 2026.
  • United Therapeutics made up ﹤0.01% of Planning Strategies's portfolio in Q3 2026, its #914 holding.
  • Planning Strategies first reported a position in United Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.